Organization Profile

You just read:

Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October

News provided by

Aeterna Zentaris Inc.

Aug 11, 2015, 07:30 ET